Colorectal cancer (CRC) presents a significant health challenge, especially with rare genetic variations complicating treatment.
Chinese Academy of SciencesAug 23 2024 Colorectal cancer presents a significant health challenge, especially with rare genetic variations complicating treatment. Traditional therapies often fall short for these unique profiles, emphasizing the need for personalized approaches. Advances in sequencing technologies have uncovered numerous rare genetic mutations tied to poor prognosis and limited response to conventional treatments.
Researchers from the State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Fourth Military Medical University, published their summary on the diagnosis and treatment of CRC with rare genetic variants in Cancer Biology & Medicine in June 2024. This study underscores the potential of advanced sequencing techniques and targeted therapies in improving patient outcomes.
The study reviews the clinical diagnosis and treatment of CRC with rare genetic variations, including mutations, amplifications, and rearrangements in genes such as ERBB2, BRAF, ALK, ROS1, NTRKs, RET, FGFR2, and EGFR. These genetic alterations often lead to poor responses to conventional therapies, necessitating precise, individualized treatment strategies.
Dr. Yuanyuan Lu, a leading researcher in the study, stated, "Our findings underscore the critical need for personalized treatment regimens for CRC patients with rare genetic variants. The integration of advanced sequencing technologies and targeted therapies holds great promise for improving patient outcomes and paving the way for more effective cancer treatments."
The study's findings have significant implications for the future of CRC treatment. By identifying specific genetic targets and developing corresponding therapies, healthcare providers can offer more precise and effective treatments, potentially improving survival rates and quality of life for CRC patients. The continued exploration and application of these targeted therapies are expected to revolutionize the management of CRC, particularly for those with rare genetic mutations.
Colorectal Colorectal Cancer Genetic Diagnostic Medicine Research
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Advances in detecting and treating rare genetic variants of colorectal cancerRecent research highlights the importance of targeted therapies for treating advanced colorectal cancer (CRC) with rare genetic variants. These mutations, often linked to poor prognosis and limited response to conventional treatments, are being addressed through advanced sequencing technologies and new targeted drugs.
Read more »
Geographic analysis pinpoints areas for improved colorectal cancer screening in Hispanic/Latino populationsCleveland Clinic-led research has identified geographic areas in the United States where strategic efforts to promote colorectal cancer screening could help reduce healthcare gaps affecting Hispanic/Latino communities.
Read more »
Research identifies priority zones that may help improve colorectal cancer screening among Hispanic/Latino individualsCleveland Clinic-led research has identified geographic areas in the United States where strategic efforts to promote colorectal cancer screening could help reduce health care gaps affecting Hispanic/Latino communities.
Read more »
Liver transplant outperforms other therapies for colorectal cancer that has spread to the liverColorectal cancer often spreads to the liver, and for some patients, surgical removal of their liver tumors is not an option.
Read more »
New study reveals how colorectal cancer cells establish liver metastasesResearchers at ETH Zurich have uncovered how colorectal cancer cells colonize the liver. Their findings could open up new ways to suppress this process in the future.
Read more »
Innovative dual-drug strategy for colorectal cancer treatmentA combination of two drugs was capable of suppressing tumors in a non-conventional manner. Instead of inhibiting tumor cell division, as the most widely used medications do, the strategy consisted of hyperactivating oncogenic signaling by these cells to the point where they became stressed.
Read more »